Home / Intelligence / Scientific Publications / Real-World Evidence on Patients with Non-Muscle Invasive Bladder Cancer Treated with BCG Therapy
This retrospective patient medical chart study aimed to assess the treatment patterns and real-world practice outcomes of NMIBC patients who were treated with BCG.
Authors
Sam Chang, Kyle Martin, Dan Shaffer, Amy Guo, Nandini Hadker
Journal
ISPOR Meeting; May 2020
Related Intelligence
Blog
Priced Out: Generic Therapy Price Competition and Drug Shortages
Introduction In the summer of 2023, many oncologists and cancer patients faced an impossible choice. Amidst many challenging treatment decisions, they had to determine how to proceed without two mainstays among oncology therapeutics: cisplatin and carboplatin. While it can sometimes be expected that there may be delays for the newest and most innovative treatments to […]
Read More
Blog
Key Takeaways and Learnings from ASH 2023
Introduction The Trinity Life Sciences’ team recently attended the 65th ASH Annual Meeting and Exposition from December 9-12, 2023, in San Diego, California. The conference brought together physicians, scientists and industry experts to share and collaborate on advances in understanding and treating blood cancers and blood disorders. Below are a few of the key insights […]
Read More
White Papers
Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology
Cell therapies are becoming increasingly incorporated as late-line standards of care across relapsed/refractory oncology indications, with an expanding ability to improve outcomes for a diverse set of tumors and patient subgroups. As the next frontier of personalized and precision medicine continues to grow, Natural Killer (NK) cell therapies offer the potential to penetrate untapped needs […]
Read More